Evidence map›Paper›PMID 38075486›Full record

ArticleInternational journal of particle therapy2023

Advancing the Role of Proton Therapy for Spine Metastases Through Diagnostic Scan-Based Planning.

Cameron W Swanick, Michael H Shang, Kevin Erhart, Jonathan Cabrera, James Burkavage, Tomas Dvorak, Naren Ramakrishna, Zhiqiu Li, Amish Shah, Sanford L Meeks and 2 more

Open access · diamondAbstract read
In one paragraph

Article in International journal of particle therapy, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.7field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 2 citations in OpenAlex.

  1. Review
  2. Article
  3. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Cameron W SwanickCenter for Advanced Radiation Therapy, Orlando Health Cancer Institute, Orlando, FL, USA.
Michael H ShangCenter for Advanced Radiation Therapy, Orlando Health Cancer Institute, Orlando, FL, USA.
Kevin Erhart.decimal, LLC, Sanford, FL, USA.
Jonathan CabreraCenter for Advanced Radiation Therapy, Orlando Health Cancer Institute, Orlando, FL, USA.
James BurkavageCenter for Advanced Radiation Therapy, Orlando Health Cancer Institute, Orlando, FL, USA.
Tomas DvorakCenter for Advanced Radiation Therapy, Orlando Health Cancer Institute, Orlando, FL, USA.
Naren RamakrishnaCenter for Advanced Radiation Therapy, Orlando Health Cancer Institute, Orlando, FL, USA.
Zhiqiu LiCenter for Advanced Radiation Therapy, Orlando Health Cancer Institute, Orlando, FL, USA.
Amish ShahCenter for Advanced Radiation Therapy, Orlando Health Cancer Institute, Orlando, FL, USA.
Sanford L MeeksVarian Medical Systems, Inc., Palo Alto, CA, USA.
Omar A ZeidanCenter for Advanced Radiation Therapy, Orlando Health Cancer Institute, Orlando, FL, USA.
Patrick KellyCenter for Advanced Radiation Therapy, Orlando Health Cancer Institute, Orlando, FL, USA.
Orlando Health · USVarian Medical Systems (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: Many patients with metastatic cancer live years beyond diagnosis, and there remains a need to improve the therapeutic ratio of metastasis-directed radiation for these patients. This study aimed to assess a process for delivering cost-effective palliative proton therapy to the spine using diagnostic scan-based planning (DSBP) and prefabricated treatment delivery devices. Materials and Methods: We designed and characterized a reusable proton aperture system that adjusts to multiple lengths for spine treatment. Next, we retrospectively identified 10 patients scan treated with thoracic proton therapy who also had a diagnostic computed tomography within 4 months of simulation. We contoured a T6-T9 target volume on both the diagnostic scans (DS) and simulation scans (SS). Using the aperture system, we generated proton plans on the DS using a posterior-anterior beam with no custom range compensator to treat T6-T9 to 8 Gy × 1. Plans were transferred to the SS to compare coverage and normal tissue doses, followed by robustness analysis. Finally, we compared normal tissue doses and costs between proton and photon plans. Results were compared using the Wilcoxon signed-rank test. Results: Median D Conclusion: Proton DSBP is technically feasible and robust, with superior sparing of the heart compared with photons. Eliminating simulation and custom devices increases the value of this approach in carefully selected patients.

Indexed as

metastasespalliativespine

Identifiers

PMID38075486
PMCPMC10698629
OpenAlexW4388479014

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.